Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
AI Maiga, DB Fofana, M Cisse, F Diallo… - Journal of …, 2012 - academic.oup.com
Objectives We describe the outcomes of second-line drug resistance profiles and predict the
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
[HTML][HTML] Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
AI Maiga, DB Fofana, M Cisse, F Diallo… - Journal of …, 2012 - ncbi.nlm.nih.gov
Objectives We describe the outcomes of second-line drug resistance profiles and predict the
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting.
AI Maiga, DB Fofana, M Cisse, F Diallo, MY Maiga… - 2012 - cabidigitallibrary.org
Objectives: We describe the outcomes of second-line drug resistance profiles and predict
the efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma …
the efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma …
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
AI Maiga, DB Fofana, M Cisse… - The Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Objectives We describe the outcomes of second-line drug resistance profiles and predict the
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
[PDF][PDF] Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
AI Maiga, DB Fofana, M Cisse, F Diallo, MY Maiga… - 2012 - researchgate.net
Objectives: We describe the outcomes of second-line drug resistance profiles and predict
the efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma …
the efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma …
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting.
AI Maiga, DB Fofana, M Cisse, F Diallo… - The Journal of …, 2012 - europepmc.org
Objectives We describe the outcomes of second-line drug resistance profiles and predict the
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
[PDF][PDF] Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
AI Maiga, DB Fofana, M Cisse, F Diallo… - J Antimicrob …, 2012 - academia.edu
Objectives: We describe the outcomes of second-line drug resistance profiles and predict
the efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma …
the efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma …
[引用][C] Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
A ISSIAKA MAIGA, D BOCAR FOFANA… - Journal of …, 2012 - pascal-francis.inist.fr
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in
Mali, a limited-resources setting CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Mali, a limited-resources setting CNRS Inist Pascal-Francis CNRS Pascal and Francis …
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
AI Maiga, DB Fofana, M Cisse… - Journal of …, 2012 - scholars.northwestern.edu
Objectives: We describe the outcomes of second-line drug resistance profiles and predict
the efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma …
the efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma …
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting.
AI Maiga, DB Fofana, M Cisse, F Diallo… - Journal of …, 2012 - search.ebscohost.com
Objectives We describe the outcomes of second-line drug resistance profiles and predict the
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …
efficacy of drugs for third-line therapy in patients monitored without the benefit of plasma HIV …